AbCellera Biologics Inc. (ABCL)
NASDAQ: ABCL · Real-Time Price · USD
4.540
-0.040 (-0.87%)
Aug 14, 2025, 11:50 AM - Market open

AbCellera Biologics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2018 - 2019
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2018 - 2019
Cash & Equivalents
92.44156.33133.32386.54476.14594.12
Upgrade
Short-Term Investments
460.64469.29627.27499.95246.84-
Upgrade
Cash & Short-Term Investments
553.08625.61760.59886.49722.98594.12
Upgrade
Cash Growth
-17.50%-17.75%-14.20%22.62%21.69%7765.96%
Upgrade
Accounts Receivable
47.3133.6230.5938.59160.58213.24
Upgrade
Other Receivables
36.0526.5333.7964.8214.280.49
Upgrade
Receivables
153.3792.1364.38103.41174.86213.73
Upgrade
Inventory
---1.531.671.41
Upgrade
Prepaid Expenses
10.78.6322.029.065.294.07
Upgrade
Restricted Cash
2525252525-
Upgrade
Total Current Assets
742.15751.37871.991,025929.8813.33
Upgrade
Property, Plant & Equipment
424.02340.43287.7217.26111.6217.92
Upgrade
Long-Term Investments
90.3782.365.9434.4232.3120.03
Upgrade
Goodwill
47.8147.8147.8147.8147.8131.5
Upgrade
Other Intangible Assets
40.2642.11120.43131.5148.39115.15
Upgrade
Long-Term Deferred Tax Assets
-----5.9
Upgrade
Other Long-Term Assets
57.4566.9480.3440.8330.641.71
Upgrade
Total Assets
1,4021,3611,4881,5411,3191,006
Upgrade
Accounts Payable
32.0434.3528.614.8314.927.32
Upgrade
Accrued Expenses
4.978.387.7125.826.5429.13
Upgrade
Current Portion of Leases
4.94.626.165.583.650.68
Upgrade
Current Income Taxes Payable
----35.6836.15
Upgrade
Current Unearned Revenue
25.1221.1826.0727.912.017.53
Upgrade
Other Current Liabilities
-8.0950.4844.2127.8722.68
Upgrade
Total Current Liabilities
67.0276.61119.01118.32120.68103.49
Upgrade
Long-Term Leases
137.1860.7471.2276.6836.413.72
Upgrade
Long-Term Unearned Revenue
179.17155.59104.1160.3260.7625.89
Upgrade
Long-Term Deferred Tax Liabilities
10.0510.0530.6133.1837.3726.16
Upgrade
Other Long-Term Liabilities
1.561.4710.8219.1437.6215.77
Upgrade
Total Liabilities
394.99304.47335.78307.63292.84175.03
Upgrade
Common Stock
791.67777.17753.2734.37722.43710.39
Upgrade
Additional Paid-In Capital
181.48166.36121.0574.1235.365.92
Upgrade
Retained Earnings
36.58116.93279.79426.19267.67114.2
Upgrade
Comprehensive Income & Other
-2.66-4.38-1.72-1.390.28-
Upgrade
Total Common Equity
1,0071,0561,1521,2331,026830.51
Upgrade
Shareholders' Equity
1,0071,0561,1521,2331,026830.51
Upgrade
Total Liabilities & Equity
1,4021,3611,4881,5411,3191,006
Upgrade
Total Debt
142.0865.3677.3882.2640.074.39
Upgrade
Net Cash (Debt)
411560.25683.21804.23682.91589.73
Upgrade
Net Cash Growth
-31.31%-18.00%-15.05%17.76%15.80%88982.48%
Upgrade
Net Cash Per Share
1.391.902.362.552.152.24
Upgrade
Filing Date Shares Outstanding
298.83297.99292.78287.69283.92269.5
Upgrade
Total Common Shares Outstanding
295.76295.76290.82286.85283.26269.5
Upgrade
Working Capital
675.12674.76752.97907.17809.12709.84
Upgrade
Book Value Per Share
3.413.573.964.303.623.08
Upgrade
Tangible Book Value
919.01966.17984.091,054829.54683.86
Upgrade
Tangible Book Value Per Share
3.113.273.383.672.932.54
Upgrade
Land
53.4153.4153.4153.4133.04-
Upgrade
Buildings
53.0452.9143.9511.361.21-
Upgrade
Machinery
93.3784.2973.8749.5626.6515.87
Upgrade
Leasehold Improvements
135.79122.8973.9440.5722.753.71
Upgrade
Updated May 8, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q